Researchers have made early progress toward a new approach to treating the deadly brain disease amyotrophic lateral sclerosis (ALS): using patients' own immune system T cells.
Oct 21, 2022
0
4
Researchers at the USF Health Morsani College of Medicine, located at the University of South Florida, successfully tested a protein that has the potential to aid in the development of a protein-based therapy for patients ...
Oct 4, 2022
0
25
Neurodegenerative diseases—like amyotrophic lateral sclerosis (ALS, or Lou Gehrig's disease), Alzheimer's, and Parkinson's—are complicated, chronic ailments that can present with a variety of symptoms, worsen at different ...
Sep 27, 2022
0
897
Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, is the most common form of motor neuron disease. People with ALS progressively lose the ability to initiate and control muscle movements, including ...
May 27, 2022
0
92
Advocacy groups are pressing U.S. federal regulators to fast-track approval of an experimental drug treatment for the deadly neurological disease ALS (amyotrophic lateral sclerosis), with a decision expected this week.
Mar 28, 2022
0
13
Unable to move a single muscle, even to open your eyes. Completely locked into your own body, yet fully conscious and aware.
Mar 22, 2022
0
363
Researchers at the University of Illinois Chicago are looking at the possibility that gastroenterological changes could be an early warning sign for Lou Gehrig's disease. Their research in animal models also shows a promising ...
Mar 18, 2022
0
41
Using an experimental drug, researchers have been able to suppress a mutated amyotrophic lateral sclerosis (ALS) gene. Studies in mice demonstrate that the therapy could show promise in treating rare, aggressive forms of ...
Jan 24, 2022
0
71
NFL players are four times more likely to die of Lou Gehrig's disease (ALS) than other people, new research finds, adding to known links between football-related head injuries and brain diseases, including Alzheimer's, Parkinson's ...
Dec 16, 2021
0
5
A team led by investigators at Massachusetts General Hospital (MGH) has shown that people living with amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, who carry a mutation in the C9orf72 gene exhibit elevated ...
Nov 15, 2021
0
14
